| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/04/2003 | US20030166632 Method for treating a disease or condition responsive to opening of C1C-2 channel |
| 09/04/2003 | US20030166630 Amino acid derivatives and their use as medicines |
| 09/04/2003 | US20030166628 Drugs such as 3-(4-chlorobenzo(b)thiophen-2-yl)-5,6-dihydro-imidazo(2,1-b)thiazole, used as hydroxytryptamine and/or noradrenaline reuptake inhibitors; anxiolytic agents |
| 09/04/2003 | US20030166610 Nutritional composition |
| 09/04/2003 | US20030166582 Aryl fused azapolycyclic compounds |
| 09/04/2003 | US20030166581 Coadministered with caffeine, for prevention of seizures; for treatment of Parkinson's/Alzheimer's disease; dietetics; smoking cessation |
| 09/04/2003 | US20030166559 Comprises tumor necrosis factor antagonist activity for treatment of autoimmune conditions |
| 09/04/2003 | US20030166553 Compositions for preventing and treating digestive organs diseases |
| 09/04/2003 | US20030166538 Isolated inflammation-related gene, the protein molecule encoded by the gene, and the use of the gene in diagnosis and treatment of inflammatory conditions. |
| 09/04/2003 | US20030166537 Use of a gial cell line-derived growth factor (GDNF) or a functionally active derivative or part thereof and/or an agonist which substitutes the functional activity of GDNF, and/ or a nucleic acid containing at least a nucleotide |
| 09/04/2003 | US20030166535 Preventing lesions of the upper alimentary canal, particularly oral aphthous or mucositis lesions. Intestinal trefoil peptides are administered in effective concentrations either alone or in combination with different therapeutic agents. |
| 09/04/2003 | US20030166534 Suppressing a class II MHC-restricted immune response in a mammal, or in mammalian cells, are described. The methods depend upon inhibiting invariant chain proteolysis by cathepsin S from class II MHC/invariant chain complexes, |
| 09/04/2003 | US20030166524 Therapeutic uses of IL-1 receptor antagonist |
| 09/04/2003 | US20030166300 Growth-related inflammatory and immune response protein |
| 09/04/2003 | US20030166284 Encoding hepatitis B virus surface antigen, treating hepatic diseases; inverted terminal repeats has the native D-sequences modified, some nucleotides are deleted or replaced; genetic engineering |
| 09/04/2003 | US20030166277 Targeted vaccine delivery systems |
| 09/04/2003 | US20030166257 Use of Lactobacillus salivarius |
| 09/04/2003 | US20030166187 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 09/04/2003 | US20030166140 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide polyadenylation sequence all |
| 09/04/2003 | US20030166044 Novel proteins |
| 09/04/2003 | US20030165816 Comprises mutant hepatitis B surface antigen for detecting viral diseases; immunoassays; kidney disorders |
| 09/04/2003 | US20030165792 System for the controlled delivery of an active material to a dental site |
| 09/04/2003 | US20030165604 In fats, oils; plant extracts |
| 09/04/2003 | US20030165569 Composition for topical substance delivery |
| 09/04/2003 | US20030165540 Sentinel virus II |
| 09/04/2003 | US20030165460 Proteins which control cell differentiation; immunology response; antiinflammatory agents; wound healing agents |
| 09/04/2003 | US20030165438 Water-free ubichinon concentrate |
| 09/04/2003 | CA2477634A1 Crystalline anhydrous and monohydrate benzoate salts of (2's,3s)-3-hydroxy-n-{2{n-methyl-n-4-(n-propylamino-carbonyl)phenyl]amino-2-phenyl}-ethylpyrrolidine |
| 09/04/2003 | CA2477558A1 N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents |
| 09/04/2003 | CA2477281A1 Method of using modified oligonucleotides for hepatic delivery |
| 09/04/2003 | CA2477231A1 Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapy |
| 09/04/2003 | CA2477178A1 Administration of agents for the treatment of inflammation |
| 09/04/2003 | CA2477105A1 Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity |
| 09/04/2003 | CA2477008A1 Substituted pyrimidinones and pyrimidinthiones |
| 09/04/2003 | CA2476896A1 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 09/04/2003 | CA2476630A1 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereof |
| 09/04/2003 | CA2476518A1 Compositions and methods for the treatment of immune related diseases |
| 09/04/2003 | CA2476316A1 Beta3-adrenergic receptor agonists |
| 09/04/2003 | CA2476173A1 Arylsulfone derivatives |
| 09/04/2003 | CA2473625A1 Oral trimethobenzamide formulations and methods |
| 09/04/2003 | CA2473602A1 Oral pediatric trimethobenzamide formulations and methods |
| 09/04/2003 | CA2473340A1 Formulations comprising a glp-1 compound and a delivery agent, and uses thereof |
| 09/03/2003 | EP1340979A2 Neuropeptide receptor and uses thereof |
| 09/03/2003 | EP1340755A1 Anti-helicobacterial agents |
| 09/03/2003 | EP1340754A1 Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 09/03/2003 | EP1339854A2 Lipid metabolism enzymes |
| 09/03/2003 | EP1339847A2 Transforming growth factor-beta-related molecules and uses thereof |
| 09/03/2003 | EP1339836A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 09/03/2003 | EP1339834A2 Enzymes |
| 09/03/2003 | EP1339748A2 G-protein coupled receptors |
| 09/03/2003 | EP1339719A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 09/03/2003 | EP1339716A1 Novel lactame-substituted pyrazolopyridine derivatives |
| 09/03/2003 | EP1339715A2 Heterocyclic ether substituted imidazoquinolines |
| 09/03/2003 | EP1339712A1 3-substituted quinuclidines and their use as nicotinic agonists |
| 09/03/2003 | EP1339711A1 Aminothiazoles and their use as adenosine receptor antagonists |
| 09/03/2003 | EP1339709A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 09/03/2003 | EP1339708A2 Indole-type inhibitors of p38 kinase |
| 09/03/2003 | EP1339707A2 Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation |
| 09/03/2003 | EP1339698A2 Pyrimidine derivatives |
| 09/03/2003 | EP1339696A1 Benzyl(idene)-lactams and their use as 5ht1-receptor ligands |
| 09/03/2003 | EP1339691A1 Novel compounds |
| 09/03/2003 | EP1339687A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 09/03/2003 | EP1339679A1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 09/03/2003 | EP1339665A1 Nitroderivatives as drugs for diseases having an inflammatory basis |
| 09/03/2003 | EP1339458A2 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |
| 09/03/2003 | EP1339430A1 Freeze-dried pantoprazole preparation and pantoprazole injection |
| 09/03/2003 | EP1339425A2 Vaccine composition containing transforming growth factor alpha |
| 09/03/2003 | EP1339420A1 Process for preparing aqueous extracts of plants and extracts so obtained |
| 09/03/2003 | EP1339419A1 Use of agents active against candida in the treatment of disorders of the oral and intestinal mucosa |
| 09/03/2003 | EP1339407A1 Farnesyl protein transferase inhibitors for the treatment of inflammatory bowel disease |
| 09/03/2003 | EP1339406A2 Piperazine derivatives, their preparation and their use for treating central nervous system (cns) disorders |
| 09/03/2003 | EP1339405A1 Use of anti-muscarinic agents and calcium channel blockers in combination |
| 09/03/2003 | EP1339402A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors |
| 09/03/2003 | EP1339394A1 Method and preparation for binding acetaldehyde in saliva, stomach and large intestine |
| 09/03/2003 | EP1339373A1 Use of moulding compounds for producing treatment devices |
| 09/03/2003 | EP1339294A1 Nutritional composition for an immune condition |
| 09/03/2003 | EP1235826B1 Quinuclidine acrylamides |
| 09/03/2003 | EP1196414B1 Prodrugs of carbamate inhibitors of impdh |
| 09/03/2003 | EP1185237B1 Synergistic antibacterial combination |
| 09/03/2003 | EP1095038B1 Antagonists of gonadotropin releasing hormone |
| 09/03/2003 | EP1070065B1 Azabicyclic 5ht1 receptor ligands |
| 09/03/2003 | EP1032381B1 Naringin and naringenin as preventive or treating agent for hepatic diseases |
| 09/03/2003 | EP0977741B1 Substituted phenyl derivatives, their preparation and use |
| 09/03/2003 | EP0977733B1 Arylsulfonylamino hydroxamic acid derivatives |
| 09/03/2003 | EP0945445B1 1,5-benzodiazepine derivatives |
| 09/03/2003 | EP0934271B1 Substituted arylalkylamines as neurokinin antagonists |
| 09/03/2003 | EP0833670B1 Vaccine against rotavirus infection comprising peptides of viral enterotoxin nsp4 |
| 09/03/2003 | CN1440456A Sentinel virus Ôàí" |
| 09/03/2003 | CN1440424A Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof |
| 09/03/2003 | CN1440418A Hyaluronic acid oligosaccharide fractions and drugs containing the same |
| 09/03/2003 | CN1440411A Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 09/03/2003 | CN1440408A Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 09/03/2003 | CN1440405A Sulfonyl-pyrrolidine derivatives useful for treatment of neurological disorders |
| 09/03/2003 | CN1440390A Substituted diamide derivatives useful as motilin antagonists |
| 09/03/2003 | CN1440383A PPARγ调制剂 PPARγ modulators |
| 09/03/2003 | CN1440270A High cleaning dentifrice |
| 09/03/2003 | CN1439423A Cordyceps sinensis buccal tablets |
| 09/03/2003 | CN1439421A Oral cavity healthy paste |
| 09/03/2003 | CN1439419A Medicinal liquor for gastrointestinal diseases and preparation thereof |
| 09/03/2003 | CN1439415A Medicament for peptic ulcer and chronic gastritis and preparation thereof |